135
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection

ORCID Icon, , , , , , & show all
Pages 133-138 | Received 14 Jan 2018, Accepted 05 Apr 2018, Published online: 03 Jul 2018

References

  • Committee Opinion No. 640: Cell-free DNA Screening for Fetal Aneuploidy . Obstet Gynecol 2015, 126(3).
  • Gregg AR. , Skotko BG. , Benkendorf JL. , et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10).10.1373/clinchem.2004.040196
  • Alberry M. , Maddocks D. , Jones M. , et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27(5):415–418.10.1002/(ISSN)1097-0223
  • Zhang H. , Gao Y. , Jiang F. et al . Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015;45(5):530–538.10.1002/uog.14792
  • Strom CM. , Anderson B. , Tsao D. et al . Improving the positive predictive value of non-invasive prenatal screening (NIPS). PLoS ONE. 2017;12(3):e0167130.10.1371/journal.pone.0167130
  • Neufeld-Kaiser WA. , Cheng EY. , Liu YJ. . Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center. BMC Med. 2015;13:129.10.1186/s12916-015-0374-8
  • Canick JA. , Palomaki GE. , Kloza EM. , et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013;33(7):667–674.10.1002/pd.4126
  • Phillips OP. , Tharapel AT. , Lerner JL. , et al. Risk of fetal mosaicism when placental mosaicism is diagnosed by chorionic villus sampling. Am J Obstet Gynecol. 1996;174(3):850–855.10.1016/S0002-9378(96)70312-5
  • Hartwig TS. , Ambye L. , Sorensen S. , et al. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn. 2017;37(6):527–539.10.1002/pd.5049
  • Grati FR. . Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J Clin Med. 2014;3(3):809–837.10.3390/jcm3030809
  • Burnham P. , Kim MS. , Agbor-Enoh S. , et al. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. Sci Rep. 2016;6:27859.10.1038/srep27859
  • Arbabi A. , Rampasek L. , Brudno M. . Cell-free DNA fragment-size distribution analysis for 280 non-invasive prenatal CNV prediction. Bioinformatics. 2016;32(11):1662–1669.10.1093/bioinformatics/btw178
  • Yu SC , Chan KC , Zheng YW et al . Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci USA. 2014;111(23):8583–8588.10.1073/pnas.1406103111
  • Alkan C. , Kidd JM. , Marques-Bonet T. et al . Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet. 2009;41(10):1061–1067.10.1038/ng.437
  • Wang T. , He Q. , Li H. et al. An optimized method for accurate fetal sex prediction and sex chromosome aneuploidy detection in non-invasive prenatal testing. PLoS One. 2016;11(7):e0159648.10.1371/journal.pone.0159648
  • Norwitz ER. , Levy B. . Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol . 2013; 6(2):48–62.
  • Dondorp W. , de Wert G. , Bombard Y. et al . Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23(11):1592.10.1038/ejhg.2015.109
  • Cuckle H. , Benn P. , Pergament E. . Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin Biochem. 2015;48(15):932–941.10.1016/j.clinbiochem.2015.02.011
  • Minarik G. , Repiska G. , Hyblova M. , Nagyova E. , et al . Utilization of benchtop next generation sequencing platforms ion torrent PGM and MiSeq in noninvasive prenatal testing for chromosome 21 trisomy and testing of impact of in silico and physical size selection on its analytical performance. PLOS ONE. 2015;10(12):e0144811.10.1371/journal.pone.0144811
  • Pescia G. , Guex N. , Iseli C. , et al. Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases. Genet Med. 2017;19(2):169–175.10.1038/gim.2016.72
  • Snyder MW. , Kircher M. , Hill AJ. , et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164(1–2):57–68.10.1016/j.cell.2015.11.050
  • Farina A. , LeShane ES. , Romero R. , et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2005;193(2):421–425.10.1016/j.ajog.2004.12.023
  • Dugoff L. , Barberio A. , Whittaker PG. , et al. Cell-free DNA fetal fraction and preterm birth. Am J Obstet Gynecol . 2016, 215(2): e231–e237.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.